Business Wire

Seoul Semiconductor Files Patent Litigation for Infringement of 12 Acrich Patents

Jaa

Seoul Semiconductor Co., Ltd. announced on September 19, 2017 that it has filed a patent infringement lawsuit, together with its affiliate, Seoul Viosys Co., Ltd., against Archipelago Lighting, Inc. in the U.S. District Court for the Central District of California.

In its complaint, Seoul asserts that Archipelago Lighting is selling various LED bulb products, including filament LED bulbs, that infringe on “twelve” (12) patents covering aspects of Seoul’s long-established Acrich technology. These Acrich patents include fundamental LED technologies, such as LED driver technology for high-voltage operation, MJT (Multi-Junction Technology), filament LED bulb structure, LED packaging, LED epitaxial growth, LED chip fabrication, etc.

In conventional LED products, one LED unit usually operates at a low voltage (3V) and high current. In order to increase brightness, one must connect many LED units through wire-bonding, but this can lead to other issues, such as an oversized, costly operating circuit, a substantial increase in manufacturing costs and defects caused by multiple wire-bonding connections.

Seoul’s Acrich technology resolves such problems by enabling the design of a high-voltage product with a high power output that relies on only a small number of LED units. Acrich technology does so by utilizing its innovative LED driver technology to enable high-voltage operation, as well as its unique MJT technology for mounting and integrating many LEDs within a small area. Seoul’s Acrich technology enables LED products to operate using AC power without requiring conversion to DC, minimizing power dissipation and reducing overall component count. This maximises the available space in LED products, facilitating a simple circuit design and significantly reducing the size and cost of LED products.

Acrich technology has become widely adopted not only in general lighting but also in electrical products and automotive lighting.

For example, in the general lighting market, 12V/18V high-voltage products have become increasingly popular, and there has been a significant increase in the demand for 36V/48V products. To manufacture such high-voltage products, Acrich technology is necessary to support LED driver technology for high-voltage operations with MJT technology. The innovative benefits of Acrich technology have resulted in its being applied in street lights and commercial lights in countries throughout the world, including locations as diverse as Korea, the United States, China, Europe, Southeast Asia, Mongolia and Kazakhstan.

In electronic products, Acrich technology is being increasingly used for valuable product lines such as large-area television displays. Acrich technology enables a dramatic enhancement in the service life and efficiency of such displays by simplifying their internal system. It also dramatically reduces the size and thickness of the final product, rendering it more pleasing to consumers, by reducing the amount of internal space previously reserved for complicated electric circuits. In particular, Acrich enables full-array local dimming that enhances the contrast range of the latest ultra-thin UHD display products by providing the next generation of backlighting solutions for high-definition displays.

Acrich technology is also expanding its application to other product areas that require high LED light output, such as landscape lighting, vehicle headlamps and day driving lights as well as mobile phone flashes.

Seoul began to develop its unique Acrich technology in the mid 1990s and has continued to launch advanced, innovative Acrich products every year following its successful mass production in 2005. Based on its decades of investment in research and development, Seoul has established a large patent portfolio for Acrich technology, including rights to approximately 1,000 Acrich patents. However, with the recent increase in the demand for high-voltage LED products, several companies have begun to manufacture products that infringe on Seoul’s Acrich patents. In order to protect its hard-earned investment against such infringement, Seoul will actively enforce its patent rights against any infringers.

Dr. Ki-bum Nam, Head of Seoul’s R&D Center and Chief Technology Officer said: “We have extensively investigated copycat products infringing on Acrich technology with various LED TVs, general lighting and automotive lighting products. In order to protect Acrich technology, which has been developed with considerable resources over many decades, we will continuously take any and all legal action against infringers that disregard our valuable intellectual property.” Nam added: “Creating a fair market that respects intellectual property is important for all innovative entrepreneurs and businesses.”

Related press photos are available herehttp://wbn-hamburg.net/cloud/public.php?service=files&t=f5a6a3d06bf01d3cb7b5b2c837abb9c3

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; Wicop – a simpler structured package-free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; NanoDriver Series –World’s Smallest 24W DC LED Drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, includes all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves over ten times the output of conventional LEDs. For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

# Trademarks

Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

Contact information

Asia
Seoul Semiconductor Co., Ltd
Jake Jung, +82 070.4391.8270
pr@seoulsemicon.com
or
Europe
Seoul Semiconductor Europe GmbH
Ariane Heim, +49 (0)89 450 3690-0
press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
David Cox, +1 (919) 410-9856
David.cox@seoulsemicon.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 12:00Tiedote

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme